Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-21 ALTSHULER DAVID EVP, Global Research and CSO Sale −1,843 $294.03 $542K 41,146
2023-02-21 ALTSHULER DAVID EVP, Global Research and CSO Sale −900 $294.73 $265K 40,246
2023-02-17 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −3,750 $292.85 $1.1M 61,441
2023-02-17 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes −4,498 $292.85 $1.3M 60,947
2023-02-17 Sanna Bastiano EVP, Cell & Genetic Therapies Shares withheld for taxes −3,750 $292.85 $1.1M 55,984
2023-02-17 Sachdev Amit EVP, Chief Patient Officer Shares withheld for taxes −3,498 $292.85 $1.0M 68,986
2023-02-17 Kewalramani Reshma CEO & President Shares withheld for taxes −9,359 $292.85 $2.7M 139,355
2023-02-17 Bozic Carmen EVP and CMO Shares withheld for taxes −3,750 $292.85 $1.1M 66,515
2023-02-17 Arbuckle Stuart A EVP, COO Shares withheld for taxes −4,498 $292.85 $1.3M 71,107
2023-02-17 ALTSHULER DAVID EVP, Global Research and CSO Shares withheld for taxes −3,750 $292.85 $1.1M 44,248
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −71 $295.89 $21K 65,694
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −20 $296.48 $6K 65,674
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −43 $297.98 $13K 65,631
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −135 $299.60 $40K 65,496
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −51 $300.58 $15K 65,445
2023-02-14 Sanna Bastiano EVP, Cell & Genetic Therapies Sale −1,902 $300.29 $571K 60,013
2023-02-14 Sanna Bastiano EVP, Cell & Genetic Therapies Sale −279 $301.11 $84K 59,734
2023-02-14 Arbuckle Stuart A EVP, COO Sale −800 $295.84 $237K 81,203
2023-02-14 Arbuckle Stuart A EVP, COO Sale −901 $296.85 $267K 80,302
2023-02-14 Arbuckle Stuart A EVP, COO Sale −560 $298.14 $167K 79,742

Page 35 of 40 · 781 trades